BRIACELL THERAPEUTICS CORP. Amortization of Intangible Assets
BRIACELL THERAPEUTICS CORP. (BCTX) reported Amortization of Intangible Assets of $15.27 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-10-16
- BRIACELL THERAPEUTICS CORP. amortization of intangible assets for fiscal 2025 was $15.27K, a 0.00% change from fiscal 2024.
- BRIACELL THERAPEUTICS CORP. amortization of intangible assets for fiscal 2024 was $15.27K, a 0.00% change from fiscal 2023.
- BRIACELL THERAPEUTICS CORP. amortization of intangible assets for fiscal 2023 was $15.27K, a 0.00% change from fiscal 2022.
- BRIACELL THERAPEUTICS CORP. amortization of intangible assets for fiscal 2022 was $15.27K, a 0.10% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 12 month |
|---|---|
| 2025-07-31 | $15.27K 10-K · filed 2025-10-16 |
| 2024-07-31 | $15.27K 10-K · filed 2025-10-16 |
| 2023-07-31 | $15.27K 10-K · filed 2024-10-29 |
| 2022-07-31 | $15.27K 10-K · filed 2023-10-25 |
| 2021-07-31 | $15.26K 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |